35 related articles for article (PubMed ID: 38602691)
1. Health care resource utilization and costs associated with psychiatric comorbidities in adult patients with attention-deficit/hyperactivity disorder.
Schein J; Cloutier M; Gauthier-Loiselle M; Bungay R; Chen K; Chan D; Childress A
J Manag Care Spec Pharm; 2024 Jun; 30(6):588-598. PubMed ID: 38824634
[TBL] [Abstract][Full Text] [Related]
2. Can Adverse Event Patterns Inform Shared Decision-Making in ADHD Treatment? A Systematic Review of Evidence From Registration Trials for FDA-Approved Treatments in Adults.
Bond JB; Walsh DM; Surman CBH
J Psychiatr Pract; 2024 May; 30(3):172-180. PubMed ID: 38819241
[TBL] [Abstract][Full Text] [Related]
3. Economic Burden of Toxicities Associated with Treating Metastatic Melanoma in the United States.
Bilir SP; Ma Q; Zhao Z; Wehler E; Munakata J; Barber B
Am Health Drug Benefits; 2016 Jun; 9(4):203-13. PubMed ID: 27688833
[TBL] [Abstract][Full Text] [Related]
4. Who Provides Outpatient Clinical Care for Adults With ADHD? Analysis of Healthcare Claims by Types of Providers Among Private Insurance and Medicaid Enrollees, 2021.
Danielson ML; Claussen AH; Arifkhanova A; Gonzalez MG; Surman C
J Atten Disord; 2024 Jun; 28(8):1225-1235. PubMed ID: 38500256
[TBL] [Abstract][Full Text] [Related]
5. What Is the Incidence of Anesthesia-Related Adverse Events in Oral and Maxillofacial Surgery Offices? A Review of 61,237 Sedation Cases From a Large Private Practice Consortium.
Wiemer SJ; Mediratta JK; Triana RR; Card J; Rallis D; Rieck KL; Holmes E; Krishnan DG
J Oral Maxillofac Surg; 2024 Apr; ():. PubMed ID: 38750658
[TBL] [Abstract][Full Text] [Related]
6. Economic implications of attention-deficit hyperactivity disorder for healthcare systems.
Leibson CL; Long KH
Pharmacoeconomics; 2003; 21(17):1239-62. PubMed ID: 14986737
[TBL] [Abstract][Full Text] [Related]
7. Health care costs of adults treated for attention-deficit/hyperactivity disorder who received alternative drug therapies.
Wu EQ; Birnbaum HG; Zhang HF; Ivanova JI; Yang E; Mallet D
J Manag Care Pharm; 2007 Sep; 13(7):561-9. PubMed ID: 17874862
[TBL] [Abstract][Full Text] [Related]
8. Comparative treatment patterns, resource utilization, and costs in stimulant-treated children with ADHD who require subsequent pharmacotherapy with atypical antipsychotics versus non-antipsychotics.
Sikirica V; Pliszka SR; Betts KA; Hodgkins P; Samuelson T; Xie J; Erder H; Dammerman R; Robertson B; Wu EQ
J Manag Care Pharm; 2012; 18(9):676-89. PubMed ID: 23206211
[TBL] [Abstract][Full Text] [Related]
9. Direct medical costs of ADHD and its comorbid conditions on basis of a claims data analysis.
Libutzki B; Ludwig S; May M; Jacobsen RH; Reif A; Hartman CA
Eur Psychiatry; 2019 May; 58():38-44. PubMed ID: 30802682
[TBL] [Abstract][Full Text] [Related]
10. Medication costs to private insurers of diversion of medications for attention-deficit hyperactivity disorder.
Aldridge AP; Kroutil LA; Cowell AJ; Reeves DB; Van Brunt DL
Pharmacoeconomics; 2011 Jul; 29(7):621-35. PubMed ID: 21473655
[TBL] [Abstract][Full Text] [Related]
11. The economic burden of common adverse events associated with metastatic colorectal cancer treatment in the United States.
Latremouille-Viau D; Chang J; Guerin A; Shi S; Wang E; Yu J; Ngai C
J Med Econ; 2017 Jan; 20(1):54-62. PubMed ID: 27603498
[TBL] [Abstract][Full Text] [Related]
12. Costs associated with adverse events during treatment episodes for adult attention-deficit/hyperactivity disorder.
Schein J; Cloutier M; Bungay R; Gauthier-Loiselle M; Childress A
J Med Econ; 2024; 27(1):653-662. PubMed ID: 38602691
[TBL] [Abstract][Full Text] [Related]
13. Cost effectiveness of pharmacotherapies for attention-deficit hyperactivity disorder: a systematic literature review.
Wu EQ; Hodgkins P; Ben-Hamadi R; Setyawan J; Xie J; Sikirica V; Du EX; Yan SY; Erder MH
CNS Drugs; 2012 Jul; 26(7):581-600. PubMed ID: 22712698
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
